TIPS Library
What is “TIPS”?
The P.I.E.C.E.S. TIPS service provides timely fax or e-mail advice on clinical and educational problems to those participating in the comprehensive P.I.E.C.E.S. Education Program. A cadre of experts provides the practical TIPS responses and advice for thinking through complex problems.
E-mailed or faxed responses are provided within a short timeframe. TIPS is one component of the on-line P.I.E.C.E.S. Resource Centre.
There have been over 1200 TIPS collected: the items in our TIPS Library represents the favourites of the Alberta P.I.E.C.E.S. Consultation Team.
Please note...
TIPS information should be used similar to the way you would use information from a textbook.
TIPS responses are not intended to serve as an individual consultation service! You should use this information in context and always work closely with the family physician involved in the care of the client and with other Partners in Care to find solutions to individual client issues.
|
Category
|
Question |
|
|
Index |
Complete index of all TIPS articles in this Library |
|
|
Question 1 |
What is the behaviour-cognitive/ mental health need? |
back to Top ^ |
|
Q1.1 |
Lifestyle choices affecting health |
|
|
Q1.2 |
Differentiate dementia and schizophrenia |
|
|
Q1.3 |
Questioning Charles Bonnet syndrome |
|
|
Question 2 |
Who is it affecting? |
back to Top ^ |
|
Q2.1 |
Working with Families |
|
|
Q2.2 |
Dealing with family concerns |
|
|
Q2.3 |
Supporting family |
|
|
Q2.4 |
Behaviour that involves stealing |
|
|
Q2.5 |
Family resistant to change |
|
|
Q2.6 |
Family coping with admission |
|
|
Q2.7 |
Family in denial |
|
|
Q2.8 |
Staff coping with family in denial |
|
|
Q2.9 |
Self care behaviour concerns |
|
|
Q2.10 |
Staff fearful |
|
|
Q2.11 |
Family refusing antipsychotic meds |
|
|
Q2.12 |
Dealing with controlling family member |
|
|
Question 3 |
What is the degree of risk? |
back to Top ^ |
|
Q3.1 |
P.I.E.C.E.S. Quick Start |
|
|
Q3.2 |
At risk for falls |
|
|
Q3.3 |
Risks of companionship |
|
|
Q3.4 |
Degree of risk |
|
|
Q3.5 |
High elopement risk |
|
|
Q3.6 |
Agitation & wandering |
|
|
Q3.7 |
Smoking risk |
|
|
Q3.8 |
Loneliness & suicidal expressions |
|
|
Q3.9 |
Risk & restraints |
|
|
Question 4 |
How do we describe & record what we see? |
|
|
Q4.1 |
Folstein |
|
|
Q4.2 |
Folstein upon admission |
|
|
Q4.3 |
Time to do DOS |
|
|
Q4.4 |
Folstein interpretation |
|
|
Q4.5 |
MMSE and repeat testing |
|
|
Q4.6 |
Cornell Scale Interpretation |
|
|
Q4.7 |
DOS assessment with incomplete data |
|
|
Q4.8 |
Differentiate between agitation & disease progression |
|
|
Q4.9 |
Which assessment tool |
|
|
Q4.10 |
Admission assessment tools |
|
|
Q4.11 |
Clock test resultS |
|
|
Q4.12 |
Wandering and rummaging |
|
|
Q4.13 |
Assessment Tool |
|
|
Q4.14 |
Accuracy of MMSE |
|
|
Q4.15 |
Assessment tools & unco-op residen |
|
|
Question 5 |
What are the possible causes? |
|
|
Q5.1 |
Misidentifcation & visual agnosia |
|
|
Q5.2 |
Sleep disturbance & elderly |
|
|
Q5.3 |
Differentiating Delerium & Dementia |
|
|
Q5.4 |
Anxiety in Dementia |
|
|
Q5.5 |
Depression in Schizophrenia |
|
|
Q5.6 |
Sudden Change in behaviour |
|
|
Q5.7 |
Rapid decline due to environmental change |
|
|
Q5.8 |
Dealing with aggressive behaviour |
|
|
Q5.9 |
Delirium as a chronic condition |
|
|
Q5.10 |
Paranoia & refusing med |
|
|
Question 6 a |
What are our best strategies - Interventions? |
|
|
Q6.1 |
Aggression management restraints & quality of life |
|
|
Q6.2 |
Attention seeking behaviour |
|
|
Q6.3 |
Snoezelen rooms |
|
|
Q6.4 |
Assistance with ADL's |
|
|
Q6.5 |
Activities for the cognitively impaired |
|
|
Q6.6 |
Dealing with staff attitudes |
|
|
Q6.7 |
Best strategies for severe depression |
|
|
Q6.8 |
Risk of inappropriate behaviour |
|
|
Q6.9 |
Dealing with flashbacks |
|
|
Q6.10 |
Resident refusing care |
|
|
Q6.11 |
Chemical restraints |
|
|
Q6.12 |
Resident refusing care 1 |
|
|
Q6.13 |
Interventions for unpredictable behaviour |
|
|
Q6.14 |
Meds sensitivity |
|
|
Q6.15 |
Chemical restraints 1 |
|
|
Q6.16 |
Best care strategies |
|
|
Question 6b |
What are our best strategies - Psychotropics? |
|
|
Q6.17 |
Benzodiazepines |
|
|
Q6.18 |
Lewy Body and Benzodiazepines |
|
|
Q6.19 |
Lewy Body Dementia |
|
|
Q6.20 |
Anxiety in the elderly |
|
|
Q6.21 |
Anxious - oral medication |
|
|
Q6.22 |
Antidepressant continue, discontinue |
|
|
Q6.23 |
Effexor and dementia & depression |
|
|
Q6.24 |
Timing of antidepressant |
|
|
Q6.25 |
Cholinergic and anticholinergic dilemma |
|
|
Q6.26 |
Nausea and antidepressants |
|
|
Q6.27 |
sychotropics & Alzheimer Disease |
|
|
Q6.28 |
Depressive syndrome & dementia |
|
|
Q6.29 |
Lewy Body and Sinemet |
|
|
Q6.30 |
EPS and Atypicals |
|
|
Q6.31 |
Antidepressants for how long |
|
|
Q6.32 |
Antidepressants & response |
|
|
Q6.33 |
Na Valporate |
|
|
Q6.34 |
Levels of Na Valporate |
|
|
Q6.35 |
Na Valporate levels - what causes elevation |
|
|
Q6.36 |
Dosing and disorders and atypicals |
|
|
Q6.37 |
elling and Psychotropics |
|
|
Q6.38 |
Anxiety-agitation choice of treatment |
|
|
Q6.39 |
Injectable antipsychotic - long acting to atypical |
|
|
Q6.40 |
Seroquel oral dose |
|
|
Q6.41 |
Psychotropics oral dose |
|
|
Q6.42 |
Sexual dysfunction |
|
|
Q6.43 |
EPS-Risperidal |
|
|
Q6.44 |
Withdrawl of antipsychotics |
|
|
Q6.45 |
Agitation Aggression |
|
|
Q6.46 |
Oral dissolving meds |
|
|
Q6.47 |
Aricept and use |
|
|
Q6.48 |
Aricept and behaviour |
|
|
Q6.49 |
Aricept and LTCF |
|
|
Q6.50 |
Cognitive enhancer benefits |
|
|
Q6.51 |
Cholinergics - when, where A |
|
|
Q6.52 |
Cholinergics - when,where B |
|
|
Q6.53 |
Screaming |
|
|
Q6.54 |
Galantamine use |
|
|
Q6.55 |
Cholinergics - place of resident |
|
|
Q6.56 |
Lewy Body Treatment |
|
|
Q6.57 |
Schizophrenia & Cognition |
|
|
Q6.58 |
Aricept - drug interactions |
|
|
Q6.59 |
Monitoring Cholinergics |
|
|
Q6.60 |
Psychotropics PRN |
|
|
Q6.61 |
Acquired Brain Injury & medication |
|
|
Q6.62 |
Screaming and psychotics after ruling out other causes |
|
|
Q6.63 |
Weight and cognitive enhanceR |
|
|
Q6.64 |
Drug Free Day |
|
|
Q6.65 |
Cognitive enhancer for what type of dementia |
|
|
Q6.66 |
Cognitive Enhancer & dementia |
|
|
Q6.67 |
Cognitive Enhancer - at what stage of dementia |
|
|
Q6.68 |
Cognitive enhancer - mod to severe dementia |
|
|
Q6.69 |
Doses of antipsychotics |
|
|
Q6.70 |
Antidepressants & dose |
|
|
Q6.71 |
Behaviour and Psychotropics |
|
|
Q6.72 |
Myasthenia Gravis treatment with cholinesterase |
|
|
Q6.73 |
Tardive Dyskinesia |
|
|
Q6.74 |
Renal dysfunction & antipsychotics |
|
|
Q6.75 |
Sleep and cognitive enhancers |
|
|
Q6.76 |
Switching Antipsychotics |
|
|
Q6.77 |
Antipsychotics & time of onset |
|
|
Q6.78 |
Trying new medicine - the family doctor & you |
|
|
Q6.79 |
Medication effective but side effects increased |
|
|
Q6.80 |
Haldol - use & side effects |
|
|
Q6.81 |
Antidepressant losing efficacy |
|
|
Q6.82 |
Celexa or colitis cause of diarrhea.pdf ( 55552 ) |
|
|
Q6.83 |
Discontinuing Zyprexa |
|
|
Q6.84 |
Side effects of antipsychotics |
|
|
Q6.85 |
Using antipsycotics PRN |
|
|
Q6.86 |
Critical questions is psychopharmacology |
|
|
Q6.87 |
Antidepressants & morphine |
|
|
Q6.88 |
Grief vs. depression & when to use antidepressants |
|
|
Q6.89 |
Pacing exit seeking meds |
|
|
Question 6 c |
What are our best strategies - General? |
|
|
Q6.90 |
Dealing with family concerns |
|
|
Q6.91 |
Assessing extent of dementia communicating to family |
|
|
Q6.92 |
Calling out behaviour |
|
|
Q6.93 |
Strategies to deal with personality disorder |
|
|
Q6.94 |
Procedure for moving to locked unit |
|
|
Q6.95 |
Mental stimulation for blind ABI resident |
|
|
Q6.96 |
Verbally inappropriate behaviour |
|
|
Q6.97 |
Managing behaviours |
|
|
Q6.98 |
Exiting behaviour |
|
|
Question 6 d |
What are our best strategies - Implementation? |
|
|
Q6.99 |
Ensure the continuity of a successful intervention |
|
|
Q6.100 |
P.I.E.C.E.S. on admission |
|
|
Q6.101 |
Partners in Care |
|
|
Q6.102 |
Dedicated time for assessments |
|
|
Q6.103 |
Monitoring Trends in Psychotropic Use |
|
|
Q6.104 |
Continuity & Temporary Staff |
|
|
Q6.105 |
Teams Taking Action |
|
|
Q6.106 |
Maintaining continuity of care |
|
|
Q6.107 |
Admission of congenital MH residents |
|
|
Q6.108 |
Adequate care and adm support |
|
|
Q6.109 |
Implementing P.I.E.C.E.S |
|
|
Q6.110 |
Assessment process in team model |
|
|
Q6.111 |
Time for assessments |
|
|
Q6.112 |
Involving others in P.I.E.C.E.S. |
|
back to Top ^ |